溃疡性结肠炎采用益生菌联合美沙拉嗪治疗的临床分析.docVIP

精品论文 参考文献 溃疡性结肠炎采用益生菌联合美沙拉嗪治疗的临床分析 湖南省岳阳市第一人民医院普通内科 湖南岳阳 414000 【摘 要】目的：观察分析溃疡性结肠炎采用益生菌联合美沙拉嗪治疗的临床效果。方法：选择2014年2月到2015年2月收治的溃疡性结肠炎患者76例做为研究对象，按照数字随机法分成两组，观察组和对照组。对照组患者使用药物美沙拉嗪，观察组患者使用益生菌联合美沙拉嗪，对比两组患者的治疗情况以及症状积分比较。结果：观察组总有效率94.74%；对照组总有效率78.95%，观察组明显高于对照组，P＜0.05；治疗前，两组患者积分无明显差异，Pgt;0.05，不具有统计学意义；两组患者经治疗后，症状积分明显降低，P＜0.05，具有统计学意义；治疗后，观察组患者的治疗积分明显低于对照组，P＜0.05，具有统计学意义。结论：单独使用美沙拉嗪对快阳性结肠炎患者有一定的治疗作用，但是效果一般，当美沙拉嗪联合益生菌治疗溃疡性结肠炎患者时，两者相互配合，治疗效果明显增加，并且副作用小，安全可靠，值得临床推广。 【关键词】溃疡性结肠炎；益生菌；美沙拉嗪；联合 Objective：To observe and analyze the clinical effect of the treatment of ulcerative colitis with probiotics combined with the United States and the United States.Methods：from February 2014 to February 2015，76 patients with ulcerative colitis were divided into two groups，the observation group and the control group according to the number of random method.Patients in the control group were treated with the drug，the observation group were treated with probiotics combined with the United States and the United States，and compared the two groups of patients with treatment and symptom scores.Results：in the observation group，the total effective rate of 94.74%；in the control group，the total efficiency was 78.95%，the observation group was significantly higher than that of the control group，P lt; 0.05).Before treatment，the score of patients in the two groups no significant difference，P gt; 0.05，does not have statistical significance；two groups of patients after treatment，symptom scores decreased significantly，P lt; 0.05，with statistical significance；after treatment，observation group treatment score was significantly lower than the control group，P lt; 0.05，with statistical significance.Conclusion：use of mesalazine alone on fast positive colitis have a certain therapeutic effect，but the general effect，when the mesalazine combined with probiotics in the treatment of patients with ulcerative colitis，in conjunction with each other，treatment significantly increased，and the side ef